Skip to main content

Table 1 Demographic characteristics and clinical manifestations of the patient population (n = 210)

From: Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China

Sociodemographic characteristics

Descriptive

 Age (years), mean (SD)

36.44 (12.83)

 Sex, female, n (%)

191 (90.95)

 Marital status, n (%)

  Married

148 (70.48)

  Other marital status

62 (29.52)

 Education level, n (%)

  Primary (0–6 years)

27 (12.86)

  Secondary (7–12 years)

78 (37.14)

  Higher (>12 years)

105 (50.00)

 Employment, n (%)

  Employed

105 (50.00)

  Unemployed

105 (50.00)

Disease characteristic

Descriptive

 Disease duration, n (%)

  <1 year

12 (5.71)

  1–5 year

98 (46.67)

   ≥ 5 year

100 (47.62)

 Comorbidities, n (%)

  0

75 (35.71)

  1

75 (35.71)

  2

33 (15.71)

   ≥ 3

27 (12.86)

 EQ-5D Index, mean (SD)

0.72 (0.26)

  SLEDAI-2 K

  0–4

98 (46.67)

  5–9

50 (23.81)

  10–14

41 (19.52)

   ≥ 15

21 (10.00)

 SLICC Index, mean (SD)

0.87(1.26)

Treatment characteristic

Descriptive

 Types of pills prescribed daily, mean (SD)

4.86 (2.20)

 Use of GC, n (%)

198 (94.29)

 Number of immunomodulators&immunosuppressants, mean (SD)

0.89 (0.70)

 Use of NSAID, n (%)

18 (8.57)

 Use of biologic drugs, n (%)

22 (10.47)

 Daily dosing frequency, n (%)

  < once daily

27 (12.86)

  once daily

46 (21.90)

  Twice daily

87 (41.43)

  Thrice daily

47 (22.38)

  > Thrice daily

3 (1.43)

 Side effects, n (%)

  0

175(83.33)

  1–2

28(13.33)

   ≥ 3

7 (3.33)

 CQR19, mean (SD)

74.06 (8.93)

  1. Abbreviations: CQR compliance questionnaire rheumatology, EQ-5D EuroQol five-dimensions, GC glucocorticoid, NSAID non-steroidal anti-inflammatory drug, SD standard deviation, SLEDAI systemic lupus erythematosus disease activity index, SLICC the Systemic Lupus International Collaborating Clinics